Clinical Trial Update: Graft Rejection or Tolerance Affected by Serial Change of Anti-donor Lymphocyte Antibody After Liver Transplantation

View source ↗

Summary

A completed trial evaluating whether serial changes in anti-donor lymphocyte antibodies influence graft rejection or tolerance after liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant Rejection

Drugs mentioned

• Anti-donor lymphocyte antibody

Snippet

Sponsor: Yonsei University | Conditions: Liver Transplant Rejection | Status: COMPLETED